Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Dig Liver Dis ; 53(5): 545-557, 2021 05.
Artículo en Inglés | MEDLINE | ID: mdl-33775575

RESUMEN

Acute liver failure (ALF) is a clinical condition characterized by the abrupt onset of coagulopathy and biochemical evidence of hepatocellular injury, leading to rapid deterioration of liver cell function. In children, ALF has been characterized by raised transaminases, coagulopathy, and no known evidence of pre-existing chronic liver disease; unlike in adults, the presence of hepatic encephalopathy is not required to establish the diagnosis. Although rare, ALF has a high mortality rate without liver transplantation (LT). Etiology of ALF varies with age and geographical location, although it may remain indeterminate in a significant proportion of cases. However, identifying its etiology is crucial to undertake disease-specific management and evaluate indication to LT. In this position statement, the Liver Disease Working Group of the Italian Society of Gastroenterology, Hepatology and Nutrition (SIGENP) reviewed the most relevant studies on pediatric ALF to provide recommendations on etiology, clinical features and diagnostic work-up of neonates, infants and children presenting with ALF. Recommendations on medical management and transplant candidacy will be discussed in a following consensus conference.


Asunto(s)
Fallo Hepático Agudo/diagnóstico , Acetaminofén/efectos adversos , Niño , Preescolar , Humanos , Lactante , Recién Nacido , Italia , Fallo Hepático Agudo/sangre , Fallo Hepático Agudo/etiología , Fallo Hepático Agudo/terapia
3.
Hepatol Int ; 13(4): 510-518, 2019 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-31069759

RESUMEN

OBJECTIVES AND STUDY: Various degrees of biliary changes are considered to be part of the histological picture of children with pediatrics autoimmune liver disease (AILD), but the literature is scarce and confusing. We aimed to describe the characteristics of children with AILD (autoimmune hepatitis, AIH, and autoimmune sclerosing cholangitis, ASC) focusing on the prevalence and type of biliary abnormalities on initial biopsy to see whether ASC was predictable on histological ground. METHODS: The files of children diagnosed with AILD were reviewed. The Ishak score was used to grade inflammation and fibrosis on biopsy; a biliary score was built to grade bile duct injury. Demographic, laboratory and histological features at diagnosis were reported and compared between the two groups (AIH vs ASC). RESULTS: Forty-one patients were diagnosed with AIH (n = 24), ASC (n = 13) and PSC (n = 4) between 2009 and 2018. Twenty-nine patients [F = 76%, AIH = 20, ASC = 9, median age at diagnosis 11.7 (range 2.2-17.8)] were included in the study; 12 (4 with PSC) were excluded. Prevalence of inflammatory bowel disease was higher in ASC group (56% vs 10% in AIH, p < 0.05). On histology 17% had cirrhosis. The grade of biliopathy with AILD was moderate in 72% and severe in 31%, and overall more prominent in ASC (p = 0.031). The inflammation of the bile ducts was classified as "multifocal" or "diffuse" mainly in ASC patients (89% vs 45% in AIH, p = 0.043). Periductular fibrosis was reported in 52% of AILD patients, with a higher mean score in ASC group (p < 0.05). However, ductular reaction, biliary metaplasia and granulomatous cholangitis were equally reported in AIH and ASC, providing no clear-cut for the distinction of the two entities in the global histological evaluation. CONCLUSIONS: Majority of patients with pediatrics AILD have "moderate" or "severe" features of biliopathy; AIH and ASC are not easily distinguishable on histological ground at diagnosis, and therefore, the cholangiogram remains the only effective tool to differentiate patients with AIH from those with ASC. Further prospective studies are needed to better define histological biliary features in AILD, assess if the biliopathy responds to immunosuppressive treatment and evaluate its impact on long-term outcome.


Asunto(s)
Colangitis Esclerosante/patología , Colangitis/patología , Hepatitis Autoinmune/patología , Adolescente , Azatioprina/administración & dosificación , Niño , Preescolar , Colangitis/tratamiento farmacológico , Colangitis Esclerosante/tratamiento farmacológico , Quimioterapia Combinada , Femenino , Hepatitis Autoinmune/tratamiento farmacológico , Humanos , Inmunosupresores/administración & dosificación , Cirrosis Hepática Biliar/patología , Linfocitos/patología , Masculino , Prednisona/administración & dosificación , Estudios Retrospectivos , Resultado del Tratamiento , Ácido Ursodesoxicólico/administración & dosificación
4.
J Toxicol Environ Health A ; 81(5): 98-105, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29265930

RESUMEN

The presence of asbestos bodies (ABs) in lung parenchyma is considered a histopathologic hallmark of past exposure to asbestos fibers, of which there was a population of longer fibers. The mechanisms underlying AB formation are complex, involving inflammatory responses and iron (Fe) metabolism. Thus, the responsiveness to AB formation is variable, with some individuals appearing to be poor AB formers. The aim of this study was to disclose the possible role of genetic variants of genes encoding inflammasome and iron metabolism proteins in the ability to form ABs in a population of 81 individuals from North East Italy, who died after having developed malignant pleural mesothelioma (MPM). This study included 86 genetic variants distributed in 10 genes involved in Fe metabolism and 7 genetic variants in two genes encoding for inflammasome molecules. Genotypes/haplotypes were compared according to the number of lung ABs. Data showed that the NLRP1 rs12150220 missense variant (H155L) was significantly correlated with numbers of ABs in MPM patients. Specifically, a low number of ABs was detected in individuals carrying the NLRP1 rs12150220 A/T genotype. Our findings suggest that the NLRP1 inflammasome might contribute in the development of lung ABs. It is postulated that the NLRP1 missense variant may be considered as one of the possible host genetic factors contributing to individual variability in coating efficiency, which needs to be taken when assessing occupational exposure to asbestos.


Asunto(s)
Proteínas Adaptadoras Transductoras de Señales/genética , Proteínas Reguladoras de la Apoptosis/genética , Amianto/toxicidad , Neoplasias Pulmonares/genética , Pulmón/patología , Mesotelioma/genética , Exposición Profesional/efectos adversos , Proteínas Adaptadoras Transductoras de Señales/metabolismo , Anciano , Anciano de 80 o más Años , Proteínas Reguladoras de la Apoptosis/metabolismo , Carga Corporal (Radioterapia) , Femenino , Variación Genética , Humanos , Italia , Pulmón/efectos de los fármacos , Neoplasias Pulmonares/metabolismo , Masculino , Mesotelioma/metabolismo , Mesotelioma Maligno , Persona de Mediana Edad , Proteínas NLR
5.
J Pediatr Nurs ; 14(6): 392-402, 1999 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-10638053

RESUMEN

The purpose of this article is to provide nurses with a comprehensive literature review of children's fears and to offer interventions that help children cope with fear. Children's normal fear development and the importance of developmental considerations in the assessment, diagnosis, and treatment of fear are also explored. A preventive model based on the work of Robinson and colleagues highlights several approaches to assist children in dealing with fear. This model provides consultation and counseling strategies that the nurse may use to help children develop control, self-worth, and security. This model may also be used to explore areas of normative developmental fears.


Asunto(s)
Adaptación Psicológica , Miedo/psicología , Proceso de Enfermería , Enfermería Pediátrica , Adolescente , Factores de Edad , Niño , Desarrollo Infantil , Preescolar , Femenino , Humanos , Lactante , Masculino , Factores Sexuales
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...